Physiologically Based Pharmacokinetic and Physiologically Based Biopharmaceutic models research in Latin America

A regional level bibliometric analysis, 2011-2023

Authors

DOI:

https://doi.org/10.1590/

Keywords:

PBPK, PBBM, Latin America Scientometric analysis, International collaboration

Abstract

The landscape of scientific research in Latin America (LA), particularly in the realms of the Physiologically Based Pharmacokinetic (PBPK) and Physiologically Based Biopharmaceutic models (PBPM), is a mosaic of varied contributions, collaborations, and specializations. This study examines research production in the region using data from the Scopus and PubMed databases collected between 2011 and 2023. Brazil stands out as a prominent country in terms of the quantity of publications. When considering thematic specialization, Colombia cones first as the country with the greatest Relative Specialization Index (RSI), followed by Brazil, Cuba, Uruguay, Mexico, and Argentina. Regarding internationalization, Brazil and Mexico are currently exerting significant influence, particularly through their increasing cooperation with the United States and Europe. Interestingly, there is a lack of cooperation inside Latin America at the regional level. Regarding the contribution of Latin-American institutions, the State University of Maringá leads in number of publications, followed by the University of São Paulo and the Federal University of São Paulo. In this work, we analyzed the strengths and weaknesses of LA’s scientific contributions, offering a roadmap for future collaborative and specialized efforts in the field of PBPK and PBBM.

Downloads

References

Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine tablets. Pharmaceutics. MPDI; 2023 May;15(5):1544.

King DA. The scientific impact of nations. Nature. 2004 Jul 15;430(6997):311-6.

Kollipara S, Martins FS, Sanghavi M, Santos GML, Saini A, Ahmed T. Role of Physiologically Based Biopharmaceutics Modeling (PBBM) in Fed Bioequivalence Study Waivers: Regulatory Outlook, Case Studies and Future Perspectives. J Pharm Sci. 2024 Feb 1;113(2):345-58.

Laisney M, Heimbach T, Mueller-Zsigmondy M, Blumenstein L, Costa R, Ji Y. Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Bioequivalence Safe-space for Ribociclib which has Permeation Rate-controlled Absorption. J Pharm Sci . 2022 Jan;111(1):274-84.

Macente J, Nauwelaerts N, Russo FM, Deprest J, Allegaert K, Lammens B, et al. PBPK-based dose finding for sildenafil in pregnant women for antenatal treatment of congenital diaphragmatic hernia. Front Pharmacol. 2023 Mar 14;14:1068153.

Martins FS, Martins JES, Severino P, Annaert P, Sy SKB. Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populations. Brit J Clinical Pharma. 2023 Sep;89(9):2726-38.

Martins FS, Sy SKB, Fonseca MJV, Freitas O de. Pharmacokinetics, Pharmacodynamics and Dermal Distribution of 5-Methoxypsoralen Based on a Physiologically Based Pharmacokinetic Model to Support Phytotherapy Using Brosimum gaudichaudii. Planta Med. Georg Thieme Verlag KG; 2020 Mar;86(04):276-83.

Martins FS, Zhu P, Heinrichs MT, Sy SKB. Physiologically based pharmacokinetic-pharmacodynamic evaluation of meropenem plus fosfomycin in paediatrics. Br J Clin Pharmacol. 2021;87(3):1012-23.

May RM. The Scientific wealth of nations. Science. AAAS. 1997 Feb 7;275(5301):793-6.

Mejia C, Wu M, Zhang Y, Kajikawa Y. Exploring Topics in Bibliometric Research Through Citation Networks and Semantic Analysis. Front. Res. Metr. Anal. 2021 Sep ; 6:742311

Patel N, Clarke JF, Salem F, Abdulla T, Martins F, Arora S, et al. Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin. CPT Pharmacometrics Syst Pharmacol. 2022 Aug;11(8):1060-84.

Rebeka J, Jerneja O, Igor L, Boštjan P, Aleksander B, Simon Ž, et al. PBPK Absorption Modeling of Food Effect and Bioequivalence in Fed State for Two Formulations with Crystalline and Amorphous Forms of BCS 2 Class Drug in Generic Drug Development. AAPS PharmSciTech. 2019 Jan 8; 20(2):59.

Saadeddin A, Purohit V, Huh Y, Wong M, Maulny A, Dowty ME, et al. Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model. AAPS J. 2024 Jan 24;26(1):17.

Severino Martins F, Borges L, Oliveira do Couto R, Schaller S, de Freitas O. Integration of artificial neural network and physiologically based biopharmaceutic models in the development of sustained-release formulations. Biopharm Drug Dispos. 2023 Aug 1;44(4):335-43.

Downloads

Published

2025-02-11

Issue

Section

Review

How to Cite

Physiologically Based Pharmacokinetic and Physiologically Based Biopharmaceutic models research in Latin America: A regional level bibliometric analysis, 2011-2023. (2025). Brazilian Journal of Pharmaceutical Sciences, 61. https://doi.org/10.1590/